World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Pricey Drugs Put Squeeze on Doctors
Keywords:
Tags:
Th cost of cancer drugs Avastin and Erbitux and the need for putting life savings at risk for a few months of treatment create tension among families, doctors and treatment providers. A course of Avastin could run $56,000 and take 90 days for reimbursement by meicare or pricate insurance, and a 20% co-pay comes to $11,200.
Genentech
06/05/2007
Genentech before and after the complete acquisition of Genentech by Roche in 2008.
Grouped Articles
How Genentech Wins At Blockbuster Drugs
Wall Street Journal 06/05/2007
Can Genentech Stage a Recovery?
Wall Street Journal 07/23/2007
BusinessWeek 12/05/2007
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Roche Offers to Buy Full Stake in Genentech
Wall Street Journal 07/22/2008
Roche Bid Blindsided Genentech
Wall Street Journal 07/22/2008
The health care models of countries in Europe.
05/02/2005
The German, French, Dutch and other models of health care. The health care system of France covers 99% of 64 million people at acost of 11% of GNP compared to 16% of GNP for the US and 50 million uninsures.
Grouped Articles
German Curbs On Drug Costs Rile Big Brands
Wall Street Journal 05/02/2005
The French Lesson in Health Care
BusinessWeek 06/28/2007
New York Times 07/14/2007
In Holland, Some See Model For U.S. Health-Care System
Wall Street Journal 09/06/2007
Maker of Lipitor Digs In to Fight Generic Rival
New York Times 11/03/2007
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.
06/09/2007
Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
New York Times 12/21/2013
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Settlement May Cut Drug Prices
Wall Street Journal 06/09/2007
Paying for universal health coverage in the U.S.
04/18/2006
The Obama administration estimates it will cost about $120 billion to cover roughly 50 million uninsured. Everything from taxing high calorie sodas, limiting tax dedcuctions for charitable giving, or decuctions for employer provided health insurance, are all being looked at Some like limiting deductions on chartable giving lack support in Congress.
Grouped Articles
Health Battle Over Soda Flares in Mexico
Wall Street Journal 08/28/2013
Recession Swells Number of Uninsured to 50.7 Million
Wall Street Journal 09/17/2010
Exchanges See Little Progress on Uninsured
Wall Street Journal 01/20/2014
Wal-Mart Cuts Prices for Many Generic Drugs to $4 - WSJ.com
Wall Street Journal 09/22/2006
A J&J Copycat Could Extend Old Drug's Life - WSJ.com
Wall Street Journal 09/29/2006
As Patients, Doctors Feel Pinch, Insurer's CEO Makes a Billion - WSJ.com
Wall Street Journal 04/18/2006
Meeting the cost concerns of governments and insurers. Efforts by pharmaceutical companies.
11/09/2006
Efforts by companies like GlaxoSMithKline to meet cost concerns of governments by linking pricing to the effectiveness of the drugs or treatments. Pharmaceutical pricing an issue with governments.
Grouped Articles
Wall Street Journal 11/09/2006
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Drug Makers Trim Prices for Health Overhaul
Wall Street Journal 06/22/2009
For Drug Makers, Concessions Have a Bright Side
Wall Street Journal 06/23/2009
New York Times 06/25/2009
The French health care system and its costs, comparison with the American system of health care.
06/28/2007
The rising costs of the French system and its concept and performance. Efforts to meet rising costs and rise of the "mutuals." Healthcare in France is at about 11% of GNP compared to 16% in the USA, with 50 million uninsured in the US and 99% of 64 million people of France covered. Pricing of pharmaceutical products and healthcare services remains a major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New York Times 12/21/2013
The French Lesson in Health Care
BusinessWeek 06/28/2007
New York Times 07/14/2007
In Holland, Some See Model For U.S. Health-Care System
Wall Street Journal 09/06/2007
Maker of Lipitor Digs In to Fight Generic Rival
New York Times 11/03/2007
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us